Skip to main content
. 2023 Feb 9;12(2):365. doi: 10.3390/antibiotics12020365
ABTS 2,2′-azinobis-3-ethylbenzothiazoline-6-sulphonic acid
A549 lung cancer cells
BCL-2 B cell CLL/lymphoma
BCL-xL B-cell lymphoma-extra large
Caco-2 colorectal cancer cells
C6 rat glioblastoma cancer cells
DPPH 2,2-diphenyl-1-picrylhydrazyl
HCC1806 breast cancer cells
HCT15 human colon carcinoma cell lines
HCT-116 human colon cancer cells
HeLa human cervix adenocarcinoma cancer cells
Hep2 human epidermoid cancer cells
HEPG2 human liver cancer cells
HEK293 normal cells
HFF-1 non-tumoral fibroblast cells
HT-29 colon cancer cells
IC50 half-maximal (50%) inhibitory concentration (IC50)
MCF-7 breast cancer cells
MCF-10A healthy breast cell line
MDA-MB-231 breast cancer cells
MIC minimal inhibitory concentration
MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
NCI-H460 human breast cancer cells
PC3 advanced prostate cancer cells
ROS reactive oxygen species
SiHa human cervical cancer cells